Lotus Mallbris, MD, PhD; Julian Davies, PhD; Andrew Glasebrook, PhD; Ying Tang, PhD; Wolfgang Glaesner, PhD; Brian J. Nickoloff, MD, PhD Eli Lilly and Company, Indianapolis, Indiana Disclosure: The authors
Peter W. Hashim, MD, MHS; John K. Nia, MD; Skylar Singer; Gary Goldenberg, MD The Icahn School of Medicine at Mount Sinai, Department of Dermatology, New York, New York Disclosure:
aLinda Stein Gold, MD; bHilary Baldwin, MD; cMaria Jose Rueda, MD; dNabil Kerrouche, MS; eBrigitte Dréno, MD, PhD aHenry Ford Hospital, Detroit, Michigan; bAcne Treatment and Research Center, Morristown, New
aGiuseppe Micali, MD; bPeter Arne Gerber, MD; aFrancesco Lacarrubba, MD; cGregor Schäfer, MD aDermatology Clinic, University of Catania, Italy; bDepartment of Dermatology, Medical Faculty, University of Düsseldorf, Germany; cGalderma International,
aTamara Agnew, BA (Hons), PhD Candidate; bGareth Furber, BPsych (Hons), PhD (Clinical Psychology); aMatthew Leach, RN, BN(Hons), ND, DipClinNutr, PhD; bLeonie Segal, B. Econ, M. Econ PhD aSchool of Nursing
aRichard R. Winkelmann, DO; bAaron S. Farberg, MD; cNatalie Tucker, BS; dRichard White, MS; eDarrell S. Rigel, MD, MS aDepartment of Dermatology, OhioHealth, Columbus, Ohio; bClinical Research Fellow, National Society
aJason M. Hirshburg, MD, PhD; bPetra A. Kelsey, BS; bChelsea A. Therrien, BS; aA. Carlo Gavino, MD; aJason S. Reichenberg, MD aDell Medical School, University of Texas at Austin, Austin,